将多功能性构建到包含造血主调控因子的复杂体系中。
Building multifunctionality into a complex containing master regulators of hematopoiesis.
机构信息
Wisconsin Institutes for Medical Research, University of Wisconsin Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA.
出版信息
Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20429-34. doi: 10.1073/pnas.1007804107. Epub 2010 Nov 8.
Developmental control mechanisms often use multimeric complexes containing transcription factors, coregulators, and additional non-DNA binding components. It is challenging to ascertain how such components contribute to complex function at endogenous loci. We analyzed the function of components of a complex containing master regulators of hematopoiesis (GATA-1 and Scl/TAL1) and the non-DNA binding components ETO2, the LIM domain protein LMO2, and the chromatin looping factor LDB1. Surprisingly, we discovered that ETO2 and LMO2 regulate distinct target-gene ensembles in erythroid cells. ETO2 commonly repressed GATA-1 function via suppressing histone H3 acetylation, although it also regulated methylation of histone H3 at lysine 27 at select loci. Prior studies defined multiple modes by which GATA-1 regulates target genes with or without the coregulator Friend of GATA-1 (FOG-1). LMO2 selectively repressed genes that GATA-1 represses in a FOG-1-independent manner. As LMO2 controls hematopoiesis, its dysregulation is leukemogenic, and its influence on GATA factor function is unknown, this mechanistic link has important biological and pathophysiological implications. The demonstration that ETO2 and LMO2 exert qualitatively distinct functions at endogenous loci illustrates how components of complexes containing master developmental regulators can impart the capacity to regulate unique cohorts of target genes, thereby diversifying complex function.
发育控制机制通常使用包含转录因子、共激活因子和其他非 DNA 结合成分的多聚体复合物。确定这些成分如何在内源性基因座中对复杂功能做出贡献是具有挑战性的。我们分析了包含造血主调控因子(GATA-1 和 Scl/TAL1)和非 DNA 结合成分 ETO2、LIM 结构域蛋白 LMO2 和染色质环化因子 LDB1 的复合物的组成成分的功能。令人惊讶的是,我们发现 ETO2 和 LMO2 在红细胞中调节不同的靶基因簇。ETO2 通常通过抑制组蛋白 H3 乙酰化来抑制 GATA-1 的功能,尽管它还在特定基因座调节组蛋白 H3 赖氨酸 27 的甲基化。先前的研究定义了 GATA-1 调节靶基因的多种模式,无论是否有共激活因子 Friend of GATA-1(FOG-1)。LMO2 选择性地抑制 GATA-1 以 FOG-1 非依赖性方式抑制的基因。由于 LMO2 控制造血,其失调是致白血病的,并且其对 GATA 因子功能的影响尚不清楚,因此这种机制联系具有重要的生物学和病理生理学意义。证明 ETO2 和 LMO2 在内源性基因座发挥定性不同的功能,说明了包含主发育调控因子的复合物的成分如何赋予调节独特靶基因群的能力,从而使复合物功能多样化。